What Researchers Did
Researchers in Japan gave hyperbaric oxygen treatment to 11 patients with painful bladder syndrome or interstitial cystitis whose symptoms had not improved with earlier therapies.
What They Found
In this small case series of 11 treatment-resistant patients, 7 had lasting symptom improvement during the 12 months after hyperbaric oxygen at 2.0 ATA. Treatment was 60 minutes a day, 5 days a week, for 2 or 4 weeks. In those 7 responders, the pelvic pain scale fell from 7.7 to 3.4 and the urgency scale from 6.6 to 4.3 after 12 months (p less than 0.05). Their interstitial cystitis symptom index score and 24-hour urinary frequency also showed a significant sustained decrease from baseline. Two responders had an additional course 12 and 13 months later and did not worsen for more than two years. Side effects were one case of transient eustachian tube dysfunction and three cases of reversible exudative otitis media.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small pilot case series of 11 patients with no comparison group, so the abstract cannot show that the treatment itself caused the improvements, and the results were reported only for the responders.